Cerny 1987 Manchester score for small-cell lung cancer: LDH above laboratory ULN, sodium <132 mmol/L, ALP >1.5×ULN, bicarbonate <24 mmol/L, Karnofsky <60, extensive stag…
Karnofsky 1949 Performance Status: caller-assigned integer 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 (normal; minor signs or symptoms; normal activity with effort; care…
Oken 1982 ECOG performance status: caller-assigned integer 0-4 (fully active; restricted strenuous activity, ambulatory, light work; ambulatory, all self-care, unable to…
Pardanani 2018 MAPS hybrid clinical-molecular (Figure 3): advanced SM 2 (ASM, SM-AHN, or MCL; ISM/SSM 0), age >60 1, platelets <150×10^9/L 1, ALP above UNL 1, ASXL1/RUNX…
Álvarez-Twose 2012 REMA: male +1, female −1; serum baseline tryptase <15 μg/L −1, 15–25 0, >25 +2; pruritus, hives or angioedema present −2, absent +1; syncope or presyn…
ICC 2022 systemic mastocytosis (Arber 2022). Met when major infiltrates (≥15 tryptase- and/or CD117-positive MCs in aggregates in BM or extracutaneous organ) alone, or ≥…
Lee 2019 Immune Effector Cell-Associated Encephalopathy (ICE) points: orientation 0-4 (year, month, city, hospital), naming 0-3 (three objects), following commands 1, wr…
NCI CTC v2.0 stomatitis/pharyngitis (Trotti 2000). none → 0; painless_or_mild_soreness → 1; painful_can_eat → 2; painful_cannot_eat → 3; parenteral_or_prophylactic_intub…
NCI CTC v2.0 Mucositis due to radiation (Trotti 2000). none → 0; erythema → 1; patchy_pseudomembrane (≤1.5 cm, noncontiguous) → 2; confluent_pseudomembrane (contiguous >…
Adult ASTCT ICANS consensus grade (Lee 2019 Table 6). Grade is the most severe of ICE, depressed LOC, seizure, deep focal motor weakness, and ICP/edema. ICE 10 is 0; 7-9…
Lee 2019 ASTCT CRS Table 1 grade 0-4. Fever (>=38 C, not another cause) with both axes none is grade 1. fever_waived after antipyretic, tocilizumab, or steroids. Grade i…
ICC 2022 prefibrotic and overt PMF (Arber 2022). Diagnosed iff 3 majors and ≥1 minor. Majors: megakaryocyte morphology, not another myeloid neoplasm, JAK2/CALR/MPL or ot…
Tefferi 2018 GIPSS for primary myelofibrosis: karyotype (favorable 0, unfavorable 1, VHR 2; caller assigns the three-tier class), absence of type 1/like CALR 1, ASXL1 1,…
Passamonti 2010 DIPSS for primary myelofibrosis: age >65 (1), WBC >25×10^9/L (1), hemoglobin <10 g/dL (2), peripheral-blood blasts ≥1% (1), constitutional symptoms (1);…
Greenberg 2012 IPSS-R for MDS: cytogenetics (very_good 0, good 1, intermediate 2, poor 3, very_poor 4; caller assigns the Schanz subgroup), BM blasts, hemoglobin g/dL, p…
Duval 2010 AML Table 5 (not ALL): PIF or CR1 >6 mo 0 / CR1 <6 mo 1; ECOG/SWOG cyto good/intermediate 0, poor 1; HLA sibling or well/partially matched unrelated 0, mismat…
Sorror 2005 HCT-specific comorbidity index. Seventeen caller-assigned comorbidities with published weights 1, 2, or 3 (max 26). Pulmonary moderate vs severe and hepatic…
Rai 1975 original CLL staging (stages 0-IV). Returns rai_stage 0-4 from caller-assigned lymphadenopathy, hepatosplenomegaly (spleen or liver or both), anemia (Hb <11 g/d…
Binet 1981 CLL staging. Stage C if anemia (Hb <10 g/dL) or thrombocytopenia (platelets <100×10^9/L), regardless of lymphoid areas. Else stage B when involved_areas is 3-…
Condoluci 2020 IPS-E for asymptomatic early-stage chronic lymphocytic leukemia: unmutated IGHV 1, ALC >15 ×10^9/L 1, palpable lymph nodes 1; max 3. Low 0, intermediate 1…
CLL-IPI 2016 for chronic lymphocytic leukaemia: TP53 abnormality (del(17p) and/or TP53 mutation) 4, unmutated IGHV 2, beta-2 microglobulin >3.5 mg/L 2, advanced stage (B…
Thieblemont 2017 MALT-IPI (IELSG-19): age ≥70, Ann Arbor III or IV, LDH > ULN; 1 point each, max 3. Low 0, intermediate 1, high ≥2. Deterministic published score with ci…
Zhou 2014 NCCN-IPI for DLBCL in the rituximab era: age (≤40 0, 41–60 1, 61–75 2, ≥76 3), LDH/ULN (≤1 0, >1–3 1, >3 2), Ann Arbor III or IV 1, major-organ extranodal (bon…
Schmitz 2016 CNS-IPI: Shipp IPI factors (age >60, ECOG ≥2, LDH > ULN, Ann Arbor III or IV, extranodal sites >1) plus kidney and/or adrenal involvement; 1 point each, max…
